vs
奥托立夫（ALV）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是奥托立夫的1.9倍（$5.5B vs $2.8B），奥托立夫净利率更高（8.0% vs 7.9%，领先0.1%），奥托立夫同比增速更快（7.7% vs -0.3%）
奥托立夫是美瑞合资的汽车安全供应商，总部位于瑞典斯德哥尔摩，在美国特拉华州注册成立，是全球最大的汽车安全系统供应商，主营安全气囊、安全带、方向盘等产品，为全球各大汽车制造商供货。品牌名由代表汽车的“auto”与瑞典语中意为“生命”的“liv”组合而成。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
ALV vs FMS — 直观对比
营收规模更大
FMS
是对方的1.9倍
$2.8B
营收增速更快
ALV
高出8.0%
-0.3%
净利率更高
ALV
高出0.1%
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8B | $5.5B |
| 净利润 | $226.0M | $434.2M |
| 毛利率 | 20.3% | 27.4% |
| 营业利润率 | 11.4% | 11.7% |
| 净利率 | 8.0% | 7.9% |
| 营收同比 | 7.7% | -0.3% |
| 净利润同比 | -7.4% | 240.4% |
| 每股收益（稀释后） | $2.97 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALVFMS
| Q4 25 | $2.8B | $5.5B | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | $5.5B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | — |
净利润ALVFMS
| Q4 25 | $226.0M | $434.2M | ||
| Q3 25 | $175.0M | — | ||
| Q2 25 | $167.0M | — | ||
| Q1 25 | $167.0M | — | ||
| Q4 24 | $244.0M | $127.6M | ||
| Q3 24 | $138.0M | — | ||
| Q2 24 | $138.0M | — | ||
| Q1 24 | $126.0M | — |
毛利率ALVFMS
| Q4 25 | 20.3% | 27.4% | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 18.5% | — | ||
| Q1 25 | 18.5% | — | ||
| Q4 24 | 21.0% | 25.0% | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | 18.2% | — | ||
| Q1 24 | 16.9% | — |
营业利润率ALVFMS
| Q4 25 | 11.4% | 11.7% | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 13.5% | 5.1% | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 7.4% | — |
净利率ALVFMS
| Q4 25 | 8.0% | 7.9% | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 9.3% | 2.3% | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 4.8% | — |
每股收益（稀释后）ALVFMS
| Q4 25 | $2.97 | — | ||
| Q3 25 | $2.28 | — | ||
| Q2 25 | $2.16 | — | ||
| Q1 25 | $2.14 | — | ||
| Q4 24 | $3.07 | — | ||
| Q3 24 | $1.74 | — | ||
| Q2 24 | $1.71 | — | ||
| Q1 24 | $1.52 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $604.0M | $1.7B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.6B | $15.4B |
| 总资产 | $8.6B | $33.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALVFMS
| Q4 25 | $604.0M | $1.7B | ||
| Q3 25 | $225.0M | — | ||
| Q2 25 | $237.0M | — | ||
| Q1 25 | $322.0M | — | ||
| Q4 24 | $330.0M | $1.3B | ||
| Q3 24 | $415.0M | — | ||
| Q2 24 | $408.0M | — | ||
| Q1 24 | $569.0M | — |
股东权益ALVFMS
| Q4 25 | $2.6B | $15.4B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.3B | $17.0B | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.4B | — |
总资产ALVFMS
| Q4 25 | $8.6B | $33.5B | ||
| Q3 25 | $8.5B | — | ||
| Q2 25 | $8.5B | — | ||
| Q1 25 | $8.1B | — | ||
| Q4 24 | $7.8B | $36.3B | ||
| Q3 24 | $8.3B | — | ||
| Q2 24 | $8.0B | — | ||
| Q1 24 | $8.3B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $544.0M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $426.0M | — |
| 自由现金流率自由现金流/营收 | 15.1% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | 2.41× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $716.0M | — |
8季度趋势，按日历期对齐
经营现金流ALVFMS
| Q4 25 | $544.0M | $2.9B | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $278.0M | — | ||
| Q1 25 | $77.0M | — | ||
| Q4 24 | $420.0M | $2.6B | ||
| Q3 24 | $177.0M | — | ||
| Q2 24 | $340.0M | — | ||
| Q1 24 | $122.0M | — |
自由现金流ALVFMS
| Q4 25 | $426.0M | — | ||
| Q3 25 | $152.0M | — | ||
| Q2 25 | $163.0M | — | ||
| Q1 25 | $-25.0M | — | ||
| Q4 24 | $281.0M | — | ||
| Q3 24 | $31.0M | — | ||
| Q2 24 | $186.0M | — | ||
| Q1 24 | $-18.0M | — |
自由现金流率ALVFMS
| Q4 25 | 15.1% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | -1.0% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 7.1% | — | ||
| Q1 24 | -0.7% | — |
资本支出强度ALVFMS
| Q4 25 | 4.2% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 5.4% | — |
现金转化率ALVFMS
| Q4 25 | 2.41× | 6.67× | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.66× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 1.72× | 20.20× | ||
| Q3 24 | 1.28× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
